Isabelle Winkles, the Chief Financial Officer of $BRZE, sold 8,274 shares of the company on 04-06-2026 for an estimated $192,866. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.8% of their shares of this class of stock. Following this trade, they now own 462,518 shares of this class of $BRZE stock.
$BRZE Insider Trading Activity
$BRZE insiders have traded $BRZE stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $BRZE stock by insiders over the last 6 months:
- WILLIAM MAGNUSON (Chief Executive Officer) has made 0 purchases and 2 sales selling 53,111 shares for an estimated $1,158,406.
- ISABELLE WINKLES (Chief Financial Officer) has made 0 purchases and 3 sales selling 33,228 shares for an estimated $735,955.
- ASTHA MALIK (Chief Business Officer) has made 0 purchases and 2 sales selling 28,371 shares for an estimated $619,387.
- SUSAN WISEMAN (General Counsel) has made 0 purchases and 5 sales selling 19,860 shares for an estimated $437,221.
- JONATHAN HYMAN (Chief Technology Officer) has made 0 purchases and 2 sales selling 17,180 shares for an estimated $385,908.
- PANKAJ MALIK (Chief Accounting Officer) has made 0 purchases and 3 sales selling 12,077 shares for an estimated $344,165.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BRZE Hedge Fund Activity
We have seen 176 institutional investors add shares of $BRZE stock to their portfolio, and 93 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. added 2,790,422 shares (+935.7%) to their portfolio in Q4 2025, for an estimated $95,683,570
- ALYESKA INVESTMENT GROUP, L.P. added 1,801,019 shares (+592.4%) to their portfolio in Q4 2025, for an estimated $61,756,941
- CADIAN CAPITAL MANAGEMENT, LP removed 1,763,108 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $60,456,973
- CHAMPLAIN INVESTMENT PARTNERS, LLC removed 1,017,288 shares (-37.8%) from their portfolio in Q4 2025, for an estimated $34,882,805
- DEUTSCHE BANK AG\ removed 992,435 shares (-60.2%) from their portfolio in Q4 2025, for an estimated $34,030,596
- VANGUARD GROUP INC added 892,635 shares (+10.0%) to their portfolio in Q4 2025, for an estimated $30,608,454
- NORGES BANK removed 870,696 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $29,856,165
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BRZE Revenue
$BRZE had revenues of $205.2M in Q4 2026. This is an increase of 27.91% from the same period in the prior year.
You can track BRZE financials on Quiver Quantitative's BRZE stock page.
$BRZE Analyst Ratings
Wall Street analysts have issued reports on $BRZE in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 03/25/2026
- Piper Sandler issued a "Overweight" rating on 03/25/2026
- Citigroup issued a "Buy" rating on 03/25/2026
- BTIG issued a "Buy" rating on 12/17/2025
- Barclays issued a "Overweight" rating on 12/10/2025
- Mizuho issued a "Outperform" rating on 12/10/2025
- Wells Fargo issued a "Overweight" rating on 12/10/2025
To track analyst ratings and price targets for $BRZE, check out Quiver Quantitative's $BRZE forecast page.
$BRZE Price Targets
Multiple analysts have issued price targets for $BRZE recently. We have seen 20 analysts offer price targets for $BRZE in the last 6 months, with a median target of $35.0.
Here are some recent targets:
- Scott Berg from Needham set a target price of $50.0 on 03/25/2026
- Billy Fitzsimmons from Piper Sandler set a target price of $27.0 on 03/25/2026
- Tyler Radke from Citigroup set a target price of $46.0 on 03/25/2026
- Gabriela Borges from Goldman Sachs set a target price of $40.0 on 03/25/2026
- Siti Panigrahi from Mizuho set a target price of $40.0 on 03/25/2026
- Alexei Gogolev from JP Morgan set a target price of $33.0 on 03/25/2026
- Brian Schwartz from Oppenheimer set a target price of $30.0 on 03/25/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
